We share with our partners a science-driven curiosity and a commitment to bring breakthrough therapeutics to patients. We understand we can nurture advances in medicine and technology beyond our company, through relationships with scientists and suppliers beyond our walls.
Taj Oncology shares a number of unique strengths with its partners. Along with our substantial financial resources, we bring a reputation for acting swiftly and being flexible. And we offer the regulatory, manufacturing, sales and marketing expertise that have led to the launches of several blockbuster products.
In drawing on the expertise of research collaborators, contract manufacturers, university researchers and suppliers, we have experienced firsthand the power of working with partners. We look forward to the opportunity to work with you.
Our dedicated staff, valued partnerships, scientific leadership and good luck have brought us great success. To further that success, Taj Oncology is engaged in active outreach to the best scientific organizations worldwide. more >
Taj Oncology has long supported extramural research with academic investigators by providing Taj Oncology products and related materials at no cost to academic institutions. more >
Taj Oncology Ventures
Our venture capital fund is designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics. more >
In this section, existing and prospective suppliers will find information about Taj Oncology's Procurement and Accounts Payable policies and practices. more >
Taj Pharma Group
A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.
Each operating company in the group develops its international business as an integral element in an overall strategy, depending on the competitive dynamics of the industry in which it operates. For some businesses a focus on the export market remains the priority. For others it is developing a robust presence in domestic markets given growing population of India. And then there are Group companies, a small but growing number, that have global ambitions; additionally, synchronizing these ventures to cater Indian market remains a priority for growth.
Exports from India remain the cornerstone of the Taj Pharma Group’s international business, but different Taj companies are increasingly investing in assets overseas through Greenfield projects (such as in Spain, Germany, Middle East, Africa, Russia, and CIS Countries), joint ventures (in Sri Lanka, UK) and acquisitions.
While individual Taj companies have differing geographical imperatives, the Taj group is focusing on a clutch of priority countries, which are expected to be of strategic importance in the years ahead. The regions are UK, Sri Lanka, the Netherlands, Germany, South Africa, members of the Gulf Cooperation Council, Brazil, Vietnam, Thailand and Taiwan.
Dr. R.K.Singh, Chairman, Taj Pharmaceuticals Limited., sums up the Taj group’s efforts to internationalize its operations thus: “We hope that a several years from now we will spread our wings far beyond India, that we become a global group, operating in many countries, an Indian business conglomerate that is at home in the world, carrying the same sense of trust that we do today." We have already progressed on such efforts by our current presence in more than 40 countries.